tiprankstipranks
Blurbs

Analysts Have Conflicting Sentiments on These NA Companies: Metagenomi, Inc. (MGX), Smith Douglas Homes Corp. Class A (SDHC) and PACS Group Inc (PACS)

Analysts have been eager to weigh in on the NA sector with new ratings on Metagenomi, Inc. (MGXResearch Report), Smith Douglas Homes Corp. Class A (SDHCResearch Report) and PACS Group Inc (PACSResearch Report).

Metagenomi, Inc. (MGX)

H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Metagenomi, Inc. today and set a price target of $10.00. The company’s shares closed last Tuesday at $6.54, close to its 52-week low of $5.50.

According to TipRanks.com, Kapoor has 0 stars on 0-5 stars ranking scale with an average return of -7.2% and a 46.5% success rate. Kapoor covers the Healthcare sector, focusing on stocks such as Rani Therapeutics Holdings, Cartesian Therapeutics, and Reneo Pharmaceuticals.

Metagenomi, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $17.67, which is a 166.1% upside from current levels. In a report issued on May 1, BMO Capital also maintained a Buy rating on the stock with a $22.00 price target.

See the top stocks recommended by analysts >>

Smith Douglas Homes Corp. Class A (SDHC)

In a report released yesterday, Michael Dahl from RBC Capital maintained a Hold rating on Smith Douglas Homes Corp. Class A, with a price target of $26.00. The company’s shares closed last Tuesday at $28.28.

According to TipRanks.com, Dahl is a 5-star analyst with an average return of 8.0% and a 58.1% success rate. Dahl covers the Industrial Goods sector, focusing on stocks such as Fortune Brands Innovations, SiteOne Landscape Supply, and Masonite International.

Currently, the analyst consensus on Smith Douglas Homes Corp. Class A is a Hold with an average price target of $28.40, implying a 7.2% upside from current levels. In a report issued on May 7, Wells Fargo also maintained a Hold rating on the stock with a $30.00 price target.

PACS Group Inc (PACS)

In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Buy rating on PACS Group Inc, with a price target of $32.00. The company’s shares closed last Tuesday at $26.91, close to its 52-week high of $27.22.

According to TipRanks.com, Hendrix is a 4-star analyst with an average return of 5.6% and a 58.0% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Walgreens Boots Alliance, and Brookdale Senior Living.

PACS Group Inc has an analyst consensus of Strong Buy, with a price target consensus of $30.60, a 18.7% upside from current levels. In a report issued on May 6, J.P. Morgan also initiated coverage with a Buy rating on the stock with a $27.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MGX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles